PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ORIOLE trial cohorts.
Andrews J, Kim Y, Horjeti E, Arafa A, Gunn H, De Bruycker A, Phillips R, Song D, Childs DS, Sartor OA, Orme JJ, Chaudhuri AA, Tran P, Kiess A, Sutera P, Mercier C, Ost P, Park SS, Lucien-Matteoni F.
Andrews J, et al. Among authors: song d.
Clin Cancer Res. 2025 Jan 16. doi: 10.1158/1078-0432.CCR-24-3027. Online ahead of print.
Clin Cancer Res. 2025.
PMID: 39820657